146062-45-5,
Keto Pioglitazone,
Keto Pioglitazone (M-III),
2,4-Thiazolidinedione,5-[[4-[2-(5-acetyl-2-pyridinyl)ethoxy]phenyl]methyl]-,
Keto PioglitazoneSee K200600,
5-[[4-[2-(5-Acetyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4thiazolidinedione,
A1-01708,
5-[[4-[2-(5-acetyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione,
5-[[4-[2-(5-acetylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione,
Ketopioglitazone,
2,4-Thiazolidinedione, 5-((4-(2-(5-acetyl-2-pyridinyl)ethoxy)phenyl)methyl)-,
2,4-Thiazolidinedione, 5-[[4-[2-(5-acetyl-2-pyridinyl)ethoxy]phenyl]methyl]-,
5-((4-(2-(5-Acetyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione,
5-({4-[2-(5-acetylpyridin-2-yl)ethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione,
AC1NPBQO,
Pioglitazone metabolite M3,
ACMC-1C04J,
CHEMBL1268,
Keto-Pioglitazone (M-III),
SCHEMBL5805530,
CTK4C4797,
DTXSID50409544,
JMLKLMFMQRAJNI-UHFFFAOYSA-N,
AKOS015837762,
RTC-071627,
DB-042821,
TC-071627,
FT-0643389,
Pioglitazone-d4 Ketone (M-III) (deuterated),
U-91324,
J-008188,
5-[4-[2-(5-acetyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione,
5-(4-(2-(5-Acetylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione,
UNII-S7979UT55L,
S7979UT55L,
CID5201446,
CS-O-08001,